Akinobu Hamada Selected Research

Gefitinib (Iressa)

1/2014	Clinical pharmacology of EGFR/Met inhibitors in non-small cell lung cancer.
6/2011	Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Akinobu Hamada Research Topics

Disease

39	Neoplasms (Cancer) 04/2024 - 02/2002
23	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 02/2006
13	Breast Neoplasms (Breast Cancer) 06/2023 - 09/2007
7	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2014 - 06/2009
6	Infections 08/2023 - 12/2004
5	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 08/2005
5	Lung Neoplasms (Lung Cancer) 10/2017 - 02/2006
5	Acute Kidney Injury (Acute Renal Failure) 12/2011 - 04/2007
4	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2020 - 01/2012
4	Prostatic Neoplasms (Prostate Cancer) 12/2008 - 08/2007
3	Disease Progression 04/2024 - 01/2020
3	COVID-19 02/2024 - 01/2021
3	Exanthema (Rash) 04/2021 - 01/2018
3	Diarrhea 04/2021 - 08/2005
3	Adenocarcinoma of Lung 03/2019 - 02/2008
2	Thymoma (Thymic Carcinoma) 04/2024 - 01/2022
2	Stomach Neoplasms (Stomach Cancer) 03/2024 - 06/2009
2	Neuroblastoma 12/2023 - 01/2018
2	Adenocarcinoma 12/2023 - 12/2023
2	Fever (Fevers) 01/2023 - 04/2021
2	Carcinosarcoma 01/2023 - 01/2023
2	Leukopenia 04/2021 - 08/2015
2	Anemia 04/2021 - 12/2004
2	Erythema Multiforme 01/2021 - 01/2020
2	Carcinoma (Carcinomatosis) 01/2021 - 06/2011
2	Neoplasm Metastasis (Metastasis) 12/2020 - 06/2011
2	Triple Negative Breast Neoplasms 10/2019 - 01/2019
2	Brain Neoplasms (Brain Tumor) 07/2019 - 01/2015
2	Body Weight (Weight, Body) 08/2016 - 12/2011
2	Testicular Neoplasms (Testicular Cancer) 01/2015 - 01/2014
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2015 - 01/2014
2	Circadian Rhythm Sleep Disorders (Delayed Sleep Phase Syndrome) 08/2009 - 11/2005
2	Subacute Sclerosing Panencephalitis (SSPE) 10/2003 - 07/2003
1	Gastritis 03/2024

Drug/Important Bio-Agent (IBA)

12	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2021 - 06/2011
8	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2011
6	Proteins (Proteins, Gene)FDA Link 12/2023 - 02/2002
6	Imatinib Mesylate (Gleevec)FDA Link 01/2014 - 04/2008
5	Carboplatin (JM8)FDA LinkGeneric 04/2024 - 12/2010
5	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2014
5	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2020
5	amrubicinIBA 01/2021 - 02/2006
5	EnzymesIBA 10/2019 - 04/2011
5	Peptides (Polypeptides)IBA 06/2016 - 08/2013
4	AntigensIBA 06/2016 - 08/2013
4	Cisplatin (Platino)FDA LinkGeneric 12/2011 - 04/2007
4	Irinotecan (Camptosar)FDA LinkGeneric 06/2009 - 08/2005
4	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 04/2008 - 02/2002
3	Docetaxel (Taxotere)FDA Link 01/2023 - 10/2016
3	NivolumabIBA 01/2022 - 03/2020
3	Trastuzumab (Herceptin)FDA Link 01/2021 - 01/2015
3	eribulin FDA Link 10/2019 - 01/2019
3	Anaplastic Lymphoma KinaseIBA 03/2019 - 01/2018
3	CrizotinibIBA 03/2019 - 08/2016
3	Gemcitabine FDA Link 04/2018 - 01/2011
3	Complementary DNA (cDNA)IBA 06/2016 - 01/2014
3	EpitopesIBA 06/2016 - 08/2013
3	IndicanIBA 12/2011 - 04/2007
3	AndrogensIBA 12/2008 - 08/2007
3	amrubicinolIBA 02/2008 - 02/2006
3	Ribavirin (Virazole)FDA LinkGeneric 12/2004 - 07/2003
2	Immunoglobulin G (IgG)IBA 02/2024 - 01/2023
2	VaccinesIBA 02/2024 - 01/2015
2	COVID-19 VaccinesIBA 02/2024 - 01/2021
2	Therapeutic UsesIBA 12/2023 - 01/2021
2	CytokinesIBA 09/2023 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 06/2023 - 08/2018
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 10/2017
2	human ERBB2 proteinIBA 01/2023 - 10/2016
2	trastuzumab deruxtecanIBA 01/2023 - 01/2023
2	pembrolizumabIBA 11/2022 - 10/2022
2	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2021 - 01/2019
2	Alanine Transaminase (SGPT)IBA 04/2021 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	AntibodiesIBA 01/2021 - 01/2021
2	olaparibIBA 10/2019 - 01/2019
2	TabletsIBA 10/2019 - 01/2019
2	Bevacizumab (Avastin)FDA Link 01/2019 - 12/2017
2	Monoclonal AntibodiesIBA 01/2018 - 10/2017
2	alectinibIBA 01/2018 - 01/2017
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2017 - 01/2013
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2014 - 08/2013
2	nilotinib FDA Link 01/2014 - 01/2011
2	Gefitinib (Iressa)FDA Link 01/2014 - 06/2011
2	CationsIBA 12/2009 - 04/2008
2	ProdrugsIBA 06/2009 - 09/2007
2	Fluorouracil (Carac)FDA LinkGeneric 06/2009 - 09/2007
2	TegafurIBA 06/2009 - 09/2007
2	VA 061 (VA061)IBA 12/2008 - 08/2007
2	Testosterone (Sustanon)FDA Link 08/2008 - 06/2008
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 04/2024
1	ripretinibIBA 04/2024
1	Platelet-Derived Growth FactorIBA 04/2024
1	lenvatinibIBA 04/2024
1	Phosphotransferases (Kinase)IBA 04/2024

Therapy/Procedure

21	Therapeutics 06/2023 - 07/2003
10	Drug Therapy (Chemotherapy) 04/2024 - 02/2006
6	Lasers (Laser) 01/2022 - 10/2017
3	Molecular Targeted Therapy 01/2023 - 01/2021
3	Immunotherapy 09/2022 - 01/2015